Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact?

S Ram1, D Blumberg, P Newton

  • 1Department of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands. WV10 0QP, UK.

Abstract

Insights

Women with rheumatoid arthritis (RA) have higher free prolactin levels compared to controls. This study clarifies that elevated total prolactin in RA patients is due to increased free prolactin, not macroprolactin.

Area of Science:

  • Endocrinology
  • Immunology
  • Rheumatology

Background:

  • Conflicting reports exist regarding serum prolactin levels in rheumatoid arthritis (RA) patients.
  • Macroprolactin, a prolactin-antibody complex, can interfere with immunoassay results, potentially explaining discrepancies.

Purpose of the Study:

  • To investigate if macroprolactin contributes to variable total prolactin measurements in RA.
  • To compare serum free and total prolactin concentrations in women with RA and healthy controls.

Main Methods:

  • Serum total and free prolactin levels were measured in 60 women with RA and 31 female controls.
  • Subjects were assessed for hyperprolactinemia and macroprolactinemia.

Main Results:

  • No participants exhibited hyperprolactinemia or macroprolactinemia.
  • Women with RA showed significantly higher serum concentrations of both total prolactin (225.6 mU/l vs 175.0 mU/l) and free prolactin (201.6 mU/l vs 154.0 mU/l) compared to controls (P<0.05).

Conclusions:

  • Serum free prolactin concentrations are elevated in women with RA.
  • The increased total prolactin levels observed in RA patients are attributable to higher free prolactin, not macroprolactin.

Related Concept Videos